Blood Bourne Viruses and screening in dialysis patients
St James University
Hospital, Leeds
The aim of the questionnaire was to establish patient opinion,
perception and understanding regarding BBV testing. This would then allow
improved testing strategies and both patient and staff awareness.
Background: Viral hepatitis is a recognised hazard
associated with dialysis. Guidelines suggest regular screening and segregation
of positive patients (Rosenheim 1972). Ideally informed consent is required but
resources for consenting with use of councillors or staff is limited and time
consuming.
Method: All dialysis patients were invited to complete
a questionnaire consisting of eight questions. Questionnaires were either given
to patients on the dialysis units or posted in the case of peritoneal dialysis
patients. Patients were invited to indicate whether they were aware about blood
borne virus testing and their perception of routine testing and how would they
want further information provided.
Results: 189 (62.5% response rate) patients completed
the questionnaire (173 haemodialysis, 16 peritoneal dialysis). 94% of patients
who received information about testing for BBV felt the information was at
least adequate (74% thought it was good or excellent). Most, 75% of patients
however did not receive counselling. Interestingly only 49% of patients felt
that counselling and consent was necessary and 45% felt they would like to
receive more information about the viruses. However 72% of patients said they
were happy to be routinely tested without prior consent or counselling and only
37% would attend counselling if offered. The average responses of don't know
was 6%. Responses between men (54%) and women were similar.
Conclusion:
These data show that patients
seem comfortable with routine testing for BBV's but half of the patients felt
consent and counselling was necessary. Appropriate staff training and
literature for informed consent for BBV testing is required in dialysis units
in a way convenient to patients.